NASDAQ
OMCL
Last Price
US $41.93
KEY FIGURES
MKT CAP
$1.8B
EPS
TTM
$0.45
PEG
TTM
N/M
P/E
TTM
90.20x
P/S
TTM
1.54x
YIELD
0.00%
GROWTH
Revenue Y/Y
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
Omnicell, Inc. cash flow to debt ratio of 62.30% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.
Financial risk - Healthy cash flow growth.
Omnicell, Inc.'s free cash flow has decreased -42.56% from $151.26M last year to $86.89M, signaling decreasing performance
Financial stability - Healthy debt to equity ratio.
Omnicell, Inc.'s debt to equity ratio is 0.16, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial stability - Healthy debt to equity ratio development.
Omnicell, Inc.'s debt has decreased relative to shareholder equity from 0.31 last year to 0.16 today, signaling strengthened financials
Financial stability - Net debt/EBITDA.
Omnicell, Inc. has a net debt to EBITDA ratio of 0.08x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
Omnicell, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.
Financial stability - Profit margin growth.
Omnicell, Inc.'s profit margin has increased (48.04%) in the last year from 1.13% to 1.67%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Omnicell, Inc.'s short-term assets of $680.07M exceed its short-term liabilities of $476.61M
Decreasing performance - ROA.
Omnicell, Inc.'s return on assets of 1.02% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Omnicell, Inc.'s return on equity of 1.64%, is lower than 15.00%, indicating bad performance
Increasing performance - Earnings quality.
Omnicell, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
Omnicell, Inc. had positive net income in 4.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Omnicell, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Omnicell, Inc. has a free cash flow yield of 4.76%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Decreasing performance - Healthy earnings growth.
Omnicell, Inc.'s yearly earnings has decreased -83.62% since last year from $12.53M to $2.05M, signaling decreasing performance
Increasing performance - Healthy revenue growth.
Omnicell, Inc.'s yearly revenue has increased 6.53% since last year from $1.11G to $1.18G, signaling increasing performance
Decreasing performance - ROIC.
ROIC 1.22% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Decreasing performance - 3-year revenue CAGR.
Omnicell, Inc.'s 3-year revenue CAGR of -2.94% is negative, indicating declining revenue over the past 3 years
Increasing performance - Revenue consistency.
Omnicell, Inc. had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Omnicell, Inc. had positive ROE in 4.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
Omnicell, Inc. is overvalued relative to its fair value price of 15.67 based on Discounted Cash Flow model
Overvalued - Earnings yield.
Omnicell, Inc. has an earnings yield of 1.12%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings
Overvalued - EBITDA valuation.
Omnicell, Inc. is overvalued relative to its fair value price of 14.67 based on EBITDA multiple model
Undervalued - EV/EBITDA.
Omnicell, Inc. has an EV/EBITDA ratio of 13.93x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Overvalued - PEG ratio value.
Omnicell, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
Omnicell, Inc. has a price-to-book ratio of 1.45x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Omnicell, Inc. has a price-to-sales ratio of 1.49x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
1.64%
Return on equity
ROIC: 1.22%
Valuation History
90.2X
Price to Earnings
EV/EBITDA: 13.9X
Cash flow
Profit margin
5.84%
(FY vs FY)
EBITDA Y/Y
-1.00%
(FY vs FY)
Cash flow Y/Y
-7.88%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $41.93
-62.63%
Default assumptions
EBITDA Multiple
Fair Value
Market $41.93
-65.01%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.